Does DEFIBROTIDE Cause Venoocclusive disease? 576 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 576 reports of Venoocclusive disease have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 15.4% of all adverse event reports for DEFIBROTIDE.
576
Reports of Venoocclusive disease with DEFIBROTIDE
15.4%
of all DEFIBROTIDE reports
125
Deaths
79
Hospitalizations
How Dangerous Is Venoocclusive disease From DEFIBROTIDE?
Of the 576 reports, 125 (21.7%) resulted in death, 79 (13.7%) required hospitalization, and 21 (3.6%) were considered life-threatening.
Is Venoocclusive disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 576 reports have been filed with the FAERS database.
What Other Side Effects Does DEFIBROTIDE Cause?
Off label use (1,323)
Death (463)
Multiple organ dysfunction syndrome (372)
Venoocclusive liver disease (355)
Intentional product use issue (201)
Hypotension (169)
Haemorrhage (156)
Sepsis (143)
Acute graft versus host disease (140)
Gastrointestinal haemorrhage (125)
What Other Drugs Cause Venoocclusive disease?
CYCLOPHOSPHAMIDE (457)
BUSULFAN (330)
FLUDARABINE (265)
CYTARABINE (240)
VINCRISTINE (239)
METHOTREXATE (237)
ETOPOSIDE (202)
DOXORUBICIN (174)
MELPHALAN (156)
CYCLOSPORINE (132)
Which DEFIBROTIDE Alternatives Have Lower Venoocclusive disease Risk?
DEFIBROTIDE vs DEFLAZACORT
DEFIBROTIDE vs DEGARELIX
DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE
DEFIBROTIDE vs DELAMANID
DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL